Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/1796 stock hub

TPEX/1796 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/1796is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/1796

In the news

Latest news · TPEX/1796

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E99.2

P25 14.4P50 18P75 31.9

ROE2

P25 -16.2P50 0.3P75 9.8

ROIC2.9

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/1796 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

TWD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	144
Enterprise value	TWD 1.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0001796001
Last refreshed	2026-05-10
Market cap	TWD 1.6B
Price	TWD 37.55
Price currency	TWD
Rev Per Employee	4,610,201.39x
Sector	Healthcare
Sic	2834
Symbol	tpex/1796
Website	https://www.geneferm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.01%
EV Earnings	99.78x
EV/EBIT	49.77x
EV/EBITDA	15.18x
EV/FCF	25.64x
EV/Sales	2.36x
FCF yield	3.92%
P/B ratio	1.99x
P/E ratio	99.16x
P/S ratio	2.35x
PE Ratio10 Y	65.22x
PE Ratio3 Y	63.44x
PE Ratio5 Y	47.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.74%
EBITDA Margin	14.75%
FCF margin	9.2%
Gross margin	26.61%
Gross Profit	TWD 176.7M
Gross Profit Growth	50.58%
Gross Profit Growth Q	-33.47%
Gross Profit Growth3 Y	-9.86%
Gross Profit Growth5 Y	4.32%
Net Income	TWD 15.7M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	-46.65%
Net Income Growth5 Y	-6.15%
Pretax Margin	3.06%
Profit Margin	2.36%
Profit Per Employee	TWD 109,028
Profitable Years	1
ROA	1.57
Roa5y	3.6
ROCE	2.9
ROE	1.99
Roe5y	7.45
ROIC	2.94
Roic5y	7.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.29%
Cagr3y	-34.35%
Cagr5y	2.62%
Div CAGR3	188.77%
Div CAGR5	32.01%
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	-46.58
EPS Growth5 Y	-11.98
FCF Growth Q	-63.59%
OCF Growth	323.41%
OCF Growth Q	-45.5%
OCF Growth10 Y	-0.99%
OCF Growth3 Y	-4.52%
OCF Growth5 Y	6.86%
Revenue Growth	16.63x
Revenue Growth Q	-7.95x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.49x
Revenue Growth5 Y	11.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.53
Assets	TWD 1.3B
Cash	TWD 278.9M
Current Assets	TWD 577M
Current Liabilities	TWD 177.8M
Debt	TWD 288.6M
Debt EBITDA	TWD 2.8
Debt Equity	TWD 0.37
Debt FCF	TWD 4.72
Equity	TWD 781.4M
Interest Coverage	5.02
Liabilities	TWD 480.8M
Long Term Assets	TWD 685.3M
Long Term Liabilities	TWD 303M
Net Cash	TWD -9.7M
Net Cash By Market Cap	TWD -0.62
Net Debt EBITDA	TWD 0.1
Net Debt Equity	TWD 0.01
Net Debt FCF	TWD 0.16
Tangible Book Value	TWD 780.4M
Tangible Book Value Per Share	TWD 18.82
WACC	4.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.24
Inventory Turnover	2.79
Net Working Capital	TWD 126.8M
Quick ratio	2.09
Working Capital	TWD 399.1M
Working Capital Turnover	TWD 1.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	TWD 0.7
Dividend Yield	1.86%
Last Dividend	TWD 2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.28%
200-day SMA	46.79
3Y total return	-71.72%
50-day SMA	39.25
50-day SMA vs 200-day SMA	50under200
5Y total return	13.77%
All Time High	158.5
All Time High Change	-76.31%
All Time High Date	2023-05-15
All Time Low	18.5
All Time Low Change	102.97%
All Time Low Date	2020-03-23
ATR	0.88
Beta	0.1
Beta1y	0.04
Beta2y	0.38
Ch YTD	-22.18
High	38.4
High52	67.1
High52 Date	2025-09-09
High52ch	-44.04%
Low	37.55
Low52	33.65
Low52 Date	2026-03-31
Low52ch	11.59%
Ma50ch	-4.33%
Price vs 200-day SMA	-19.75%
RSI	40.95
RSI Monthly	40.74
RSI Weekly	33.81
Sharpe ratio	-0.59x
Sortino ratio	-0.75
Total Return	1.86%
Tr YTD	-22.18
Tr1m	-8.64%
Tr1w	-0.66%
Tr3m	-15.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 31.5M
Operating Income Growth3 Y	-35.78
Operating Income Growth5 Y	-3.72
Operating margin	4.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,671,574%
Net Borrowing	-39,751,000
Shares Insiders	9.52%
Shares Out	41,459,793
Shares Qo Q	-0.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 61.1M
Average Volume	20,409.7x
Bv Per Share	18.85
CAPEX	TWD -25.2M
Ch1m	-8.64
Ch1w	-0.66
Ch1y	-20.28
Ch3m	-15.24
Ch3y	-72.99
Ch5y	5.78
Ch6m	-24.6
Change	-2.09%
Change From Open	-2.21
Close	38.35
Days Gap	0.13
Depreciation Amortization	66,455,000
Dollar Volume	1,915,050
Earnings Date	2026-05-11
EBIT	TWD 31.5M
EBITDA	TWD 97.9M
EPS	TWD 0.38
F Score	7
FCF	TWD 61.1M
FCF EV Yield	3.9x
FCF Per Share	TWD 1.47
Financing CF	-39,751,000
Fiscal Year End	December
Founded	1,999
Graham Number	12.67232
Graham Upside	-66.25
Income Tax	TWD 4.6M
Investing CF	-24,984,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2026-03-31
Lynch Fair Value	TWD 1.89
Lynch Upside	-94.96
Ma150	45.65
Ma150ch	-17.75%
Ma20	38.95
Ma20ch	-3.59%
Net CF	21,700,000
Next Earnings Date	2026-05-11
Open	38.4
P FCF Ratio	25.48
P OCF Ratio	18.04
Position In Range	0
Ppne	664,167,000
Price Date	2026-05-08
Price EBITDA	TWD 15.9
Ptbv Ratio	1.99
Relative Volume	2.67x
Revenue	663,869,000x
Tax By Revenue	0.7x
Tax Rate	22.79%
Tr6m	-24.6%
Volume	51,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/1796 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$0.70 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+32.0%

Annualized growth of the per-share dividend

Total shareholder yield

+1.9%

Dividend yield + buyback yield combined

Performance

TPEX/1796 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/1796?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+9.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/1796 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.9

Neutral momentum band

Price vs 200-day MA

-19.7%

50/200-day relationship not available

Beta (5Y)

0.10

Less volatile than the market

Sharpe ratio

-0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/1796

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/1796 stock rating?

tpex/1796 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/1796 analysis?

The full report lives at /stocks/tpex/1796/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/1796?

The latest report frames tpex/1796 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/1796 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.